good find; press co's using the tried and true approaches.
Great question. I'm sure the almighty regulators believe they have to follow no rules regarding their own communications; just the peasants do.
The numbers better be huge b/c there are probably about 30,000,000+ more shares now over the past two weeks due to the ATM secondary. that is why i'm not touching it. This could be stuck in Park for an indefinite amount of time now. Too bad for me I dumped shares i had at 0.72. Anyone serious here have a handle on how to reasonably look at the dilution right now???
The data definitely seems good, and good enough to propel this story much further down the road. The additional studies are going to continue to complement the work that's been done; I think we're going to be gravitating through the teens here in coming weeks/months gl!
Two high volume breakouts from orderly consolidation patterns this year; both of these were followed by low volume ebbs, which is also bullish. Technicals look good for push over $20+. Fundamentals also good i think, with more positive news expected. I am comfy holding this right now, and I am very rarely comfy holding anything. GL
I think today's action was a solid indication of where this stock is headed...up 2%+ in a bloody market. 40%+ short interest, positive (EU) news cycles likely coming...i think we're in for a good ride here in coming wks if mkt can hold together. I love high short interest stocks when the story changes for the better...made a killing in GMCR in 2012-13 in similar scenario. I bt in 6's and was gonna trade it, but I'm thinking hold/add. GL.
Well, as a total guess, I'd say pop at least to 9-12 range and then trading upward from there after consolidating in that range for a month or so. With this much short interest, though, it could get taken for a run to the teens and maybe to twenty+ this yr. I don't see the data as insignificant and believe the market is going to start pricing in potentially very good financial benefits to OREX if further data corroborates.
I agree w/ you and gilman above. About $1.5B in mkt cap shed in a few hrs over what will likely amount to a 3-4 month delay, if not less. Sheesh. Look at the SLXP and PCYC buyout activity....there are many potential acquirers of co's that have good product, and ACAD is one of them. My guess is this will be trading 60's - 80's by end of yr on its own and will be able to sell itself higher than that in '16. I thought i had missed boat on this one but am glad to be new owner at this price.
Quote from press release:
"These results are clinically significant because they show that checkpoint blockade can be safely combined with TIL therapy...."
The words "clinically significant "are pretty much what you want to be seeing as a bio investor.
Great data imo.
This reminds me of GMCR in late 2012. Brian Kelley joined as CEO from KO when GMCR was about 25-30. Stock triples over preceding 6+ months and then KO announces multiple investments in GMCR, sending to 150 by mid 2014. Got a triple in that one, but could have had much more if hadn't been shaken out. Sitting tight on this one. GL.
yeah thru "it". LOL. Like inventory restating SLXP 4 mo's ago, then bt out 100% higher. I've been through "it", too.
A month or so ago, someone posted info on a website run by a long time CYTX investor; the site is about CYTX and has a lot of detailed info about the co. I tried to find the post but can't. If anyone knows what i'm talking about and would care to repost, I (and maybe others on here) would appreciate same. thx.